跳至主要内容
临床试验/NCT06228911
NCT06228911已完成不适用

Increased Blood Glucose Levels After Steroid Injection Into Osteoarthritic Knee in Diabetic Patients' Type 2

Syrian Private University1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2020年1月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
600
试验地点
1
主要终点
high blood glucose

研究概览

简要总结

a sample of 600 patients diagnosed as Knee osteoarthritis injected with 40 mg triamcinolone, recorded their morning fasting blood glucose levels for 7 days before injection used as the baseline blood glucose level, which was compared with FBS levels for 14 days after steroid injection. Our study compared the differences in blood glucose changes between HbA1c >7% and HbA1c ≤7% groups and those between insulin and non-insulin treated groups.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Factorial
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years, patients with knee osteoarthritis diagnosed according to American College of Rheumatology (ACR) Criteria (17), and grade1-3 in Kallgren-Laurence radiographic scale (18), whom failed to response to medical treatment including paracetamol and nonsteroidal anti-inflammatory medication, and to physical therapy, checking their blood glucose values daily.

排除标准

  • Patients who were unable to provide consent, patients had any contraindications to corticosteroids, patients who had received oral corticosteroid in the past 6 months or corticosteroid injection in the previous 3 months, patients who had no monitoring HbA1c level before injection or also whom had not monitor blood glucose levels before or after injection.

研究组 & 干预措施

insulin treated group

Experimental

干预措施: steroid (triamcinolone) (Drug)

non-insulin treated groups

Experimental

干预措施: steroid (triamcinolone) (Drug)

结局指标

主要结局

high blood glucose

时间窗: 3 years

glucose increases after steroid dose

low blood glucose

时间窗: 3 years

glucose decreases after steroid dose

次要结局

未报告次要终点

研究者

发起方
Syrian Private University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Diaa Haj Ali

Medical Doctor Diaa Haj Ali

Syrian Private University

研究点 (1)

Loading locations...

相似试验